Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model

Journal of Korean Medical Science

Volumn 28, Issue 4, 2013, Pages 608-613

  Shin, Joo Young ^a   Sohn, Joonhong ^b   Park, Kyu Hyung ^c  

^a Seoul National University Hospital   (South Korea)

^b Hangil Eye Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Blood retinal barrier.; Chlorogenic acid; Diabetes rat model; Diabetic retinopathy; Vascular endothelial growth factor

Indexed keywords

CHLOROGENIC ACID; CLAUDIN 5; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; OCCLUDIN; PROTEIN ZO1; TIGHT JUNCTION PROTEIN; TJP1 PROTEIN, RAT; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLOOD RETINA BARRIER; CHEMISTRY; DIABETES RAT MODEL; DIABETIC RETINOPATHY; DOWN REGULATION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; MALE; METABOLISM; PATHOLOGY; RAT; RETINA; SPRAGUE DAWLEY RAT;

BLOOD-RETINAL BARRIER; CHLOROGENIC ACID; DIABETES RAT MODEL; DIABETIC RETINOPATHY; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANIMALS; BLOOD-RETINAL BARRIER; CHLOROGENIC ACID; CLAUDIN-5; DEXTRANS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DOWN-REGULATION; FLUORESCEIN-5-ISOTHIOCYANATE; MALE; OCCLUDIN; RATS; RATS, SPRAGUE-DAWLEY; RETINA; TIGHT JUNCTION PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84877804288     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.4.608     Document Type: Article

References (27)

1. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells: Penn State Retina Research Group. Diabetes 1998; 47: 1953-9.
2. Barber AJ, Antonetti DA. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest Ophthalmol Vis Sci 2003; 44: 5410-6.
3. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes: the Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000; 41: 3561-8.
4. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1: a potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999; 274: 23463-7.
5. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 2006; 47: 5106-15.
6. Hirase T, Staddon JM, Saitou M, Ando-Akatsuka Y, Itoh M, Furuse M, Fujimoto K, Tsukita S, Rubin LL. Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 1997; 110: 1603- 13.
7. Turksen K, Troy TC. Barriers built on claudins. J Cell Sci 2004; 117: 2435- 47.
8. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, Okada Y, Ikeda E. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 2007; 170: 1389-97.
9. Wittchen ES, Haskins J, Stevenson BR. Protein interactions at the tight junction: actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 1999; 274: 35179-85.
10. Dos Santos MD, Almeida MC, Lopes NP, de Souza GE. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 2006; 29: 2236-40.
11. Puupponen-Pimiä R, Nohynek L, Meier C, Kähkönen M, Heinonen M, Hopia A, Oksman-Caldentey KM. Antimicrobial properties of phenolic compounds from berries. J Appl Microbiol 2001; 90: 494-507.
12. Ma CM, Kully M, Khan JK, Hattori M, Daneshtalab M. Synthesis of chlorogenic acid derivatives with promising antifungal activity. Bioorg Med Chem 2007; 15: 6830-3.
13. Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 2010; 48: 937-43.
14. Lee JH, Park JH, Kim YS, Han Y. Chlorogenic acid, a polyphenolic compound, treats mice with septic arthritis caused by Candida albicans. Int Immunopharmacol 2008; 8: 1681-5.
15. Xu Y, Chen J, Yu X, Tao W, Jiang F, Yin Z, Liu C. Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice. Inflamm Res 2010; 59: 871-7.
16. Kim C, Yu HG, Sohn J. The anti-angiogenic effect of chlorogenic acid on choroidal neovascularization. Korean J Ophthalmol 2010; 24: 163-8.
17. Shi H, Dong L, Bai Y, Zhao J, Zhang Y, Zhang L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol 2009; 623: 119-24.
18. McCarty MF. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med Hypotheses 2005; 64: 848-53.
19. Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, Hemmerle H, Schubert G, Below P, Herling AW. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 1997; 339: 315-22.
20. Herling AW, Burger H, Schubert G, Hemmerle H, Schaefer H, Kramer W. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol 1999; 386: 75-82.
21. Rodriguez de Sotillo DV, Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 2002; 13: 717-26.
22. Ong KW, Hsu A, Tan BK. Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes. PLoS One 2012; 7: e32718.
23. Gonthier MP, Verny MA, Besson C, Rémésy C, Scalbert A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 2003; 133: 1853-9.
24. Bucolo C, Ward KW, Mazzon E, Cuzzocrea S, Drago F. Protective effects of a coumarin derivative in diabetic rats. Invest Ophthalmol Vis Sci 2009; 50: 3846-52.
25. Leal EC, Martins J, Voabil P, Liberal J, Chiavaroli C, Bauer J, Cunha-Vaz J, Ambrósio AF. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 2010; 59: 2637-45.
26. Kim JH, Kim JH, Yu YS, Min BH, Kim KW. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 2010; 51: 1659-65.
27. Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003; 78: 728-33.